z-logo
open-access-imgOpen Access
Fatal Isoniazid Hepatotoxicity in the Deployed Environment
Author(s) -
Daniel J Cybulski,
Brian White
Publication year - 2020
Publication title -
military medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 67
eISSN - 1930-613X
pISSN - 0026-4075
DOI - 10.1093/milmed/usaa414
Subject(s) - isoniazid , software deployment , anticipation (artificial intelligence) , medicine , tuberculosis , military medicine , drug , medical emergency , intensive care medicine , pharmacology , pathology , computer science , political science , law , artificial intelligence , operating system
Deployed clinicians have limited resources at their disposal to augment medical decision-making and management. All deploying personnel undergo predeployment medical assessment to evaluate their fitness for deployment. The purpose of predeployment screening is to allow for anticipation of medical needs that may arise which could challenge the available medical resources in an expeditionary environment. Medical standards for deployment are published, identifying disqualifying conditions and medications. A history of latent tuberculosis infection is not disqualifying for deployment. Isoniazid is not specifically mentioned as a disqualifying medication, though it is well known to have the potential of causing drug-induced liver injury. Here, a case of fatal isoniazid-induced drug-induced liver injury in a deployed setting is presented with a review of current latent tuberculosis infection literature. Our goal is for the reader to form their own opinion whether or not isoniazid should be used in the forward environment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom